Bruno Larrivée
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Genetics top 2%
- Vascular Anomalies and Treatments
Papers in
-
- Angiogenesis and VEGF in Cancer 23
- TGF-β signaling in diseases 4
- Oncology 9
- Lymphatic System and Diseases 4
- Co-authors
- Claire Viallard (4 shared papers)Anne Eichmann (18 shared papers)Aly Karsan (10 shared papers)Thomas Mathivet (4 shared papers)Catarina Freitas (5 shared papers)Claudia Prahst (4 shared papers)António Duarte (2 shared papers)Steven Suchting (3 shared papers)
- Journals
- Scientific Reports (4 papers)Blood (3 papers)Angiogenesis (3 papers)The Journal of Cell Biology (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- CanadaFranceUnited States
In The Last Decade
Bruno Larrivée
50 papers receiving 4.4k citations
Bruno Larrivée's Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 689
- Genetics 465
- Molecular Biology 2.3k
- Oncology 788
- Cellular and Molecular Neuroscience 521
Countries citing papers authored by Bruno Larrivée
This map shows the geographic impact of Bruno Larrivée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Larrivée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Larrivée more than expected).
Fields of papers citing papers by Bruno Larrivée
This network shows the impact of papers produced by Bruno Larrivée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Larrivée. The network helps show where Bruno Larrivée may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruno Larrivée, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor angiogenesis and vascular normalization: alternative therapeutic targets Hit paper breakdown → | 2017 | 1139 |
| 2 | 2010 | 362 | |
| 3 | 2012 | 302 | |
| 4 | 2010 | 286 | |
| 5 | 2010 | 286 | |
| 6 | 2009 | 221 | |
| 7 | 2007 | 184 | |
| 8 | 2002 | 147 | |
| 9 | 2016 | 139 | |
| 10 | 2016 | 130 | |
| 11 | 2021 | 107 | |
| 12 | 2000 | 101 | |
| 13 | 2005 | 62 | |
| 14 | 2013 | 60 | |
| 15 | 2012 | 56 | |
| 16 | 2018 | 56 | |
| 17 | 2022 | 54 | |
| 18 | 2012 | 54 | |
| 19 | 2020 | 54 | |
| 20 | 2008 | 53 |
About Bruno Larrivée
Bruno Larrivée is a scholar working on Molecular Biology, Oncology, Genetics, Cellular and Molecular Neuroscience and Cancer Research, having authored 53 papers that have together received 4.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (23 papers), Axon Guidance and Neuronal Signaling (7 papers), Vascular Malformations and Hemangiomas (6 papers), Vascular Anomalies and Treatments (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Lymphatic System and Diseases (4 papers), TGF-β signaling in diseases (4 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (4 papers). The work is most often cited by research in Cancer Research (689 citations), Genetics (465 citations), Molecular Biology (2.3k citations), Oncology (788 citations) and Cellular and Molecular Neuroscience (521 citations). Bruno Larrivée has collaborated with scholars based in Canada, France and United States. Frequent co-authors include Claire Viallard, Anne Eichmann, Aly Karsan, Thomas Mathivet, Catarina Freitas, Claudia Prahst, António Duarte, Steven Suchting, Christiane Bréant and Michael Simons. Their work appears in journals such as Scientific Reports, Blood, Angiogenesis, The Journal of Cell Biology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.